184 related articles for article (PubMed ID: 31509713)
1. An update on polymyxin susceptibility testing methods for
Dafopoulou K; Vourli S; Tsakris A; Pournaras S
Expert Rev Anti Infect Ther; 2019 Sep; 17(9):699-713. PubMed ID: 31509713
[No Abstract] [Full Text] [Related]
2. Comparative Evaluation of Broth Microdilution with Polystyrene and Glass-Coated Plates, Agar Dilution, E-Test, Vitek, and Disk Diffusion for Susceptibility Testing of Colistin and Polymyxin B on Carbapenem-Resistant Clinical Isolates of Acinetobacter baumannii.
Singhal L; Sharma M; Verma S; Kaur R; Britto XB; Kumar SM; Ray P; Gautam V
Microb Drug Resist; 2018 Oct; 24(8):1082-1088. PubMed ID: 29406804
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of disc diffusion, E-test, and broth microdilution methods for the determination of resistance to colistin, polymyxin B, and tigecycline in multi-resistant Acinetobacter baumannii isolates].
Akin FE; Bayram A; Balci I
Mikrobiyol Bul; 2010 Apr; 44(2):203-10. PubMed ID: 20549954
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis.
Lyu C; Zhang Y; Liu X; Wu J; Zhang J
BMC Infect Dis; 2020 Apr; 20(1):296. PubMed ID: 32316926
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of two automated systems for colistin susceptibility testing of carbapenem-resistant Acinetobacter baumannii clinical isolates.
Vourli S; Dafopoulou K; Vrioni G; Tsakris A; Pournaras S
J Antimicrob Chemother; 2017 Sep; 72(9):2528-2530. PubMed ID: 28605445
[TBL] [Abstract][Full Text] [Related]
7. Performances of the Rapid Polymyxin
Lescat M; Poirel L; Jayol A; Nordmann P
Microb Drug Resist; 2019 May; 25(4):520-523. PubMed ID: 30508392
[No Abstract] [Full Text] [Related]
8. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii.
Thomas VM; Brown RM; Ashcraft DS; Pankey GA
Int J Antimicrob Agents; 2019 May; 53(5):663-668. PubMed ID: 30880230
[TBL] [Abstract][Full Text] [Related]
9. Polymyxin B Etest
Kulengowski B; Ribes JA; Burgess DS
Clin Microbiol Infect; 2019 Jan; 25(1):92-95. PubMed ID: 29674129
[TBL] [Abstract][Full Text] [Related]
10. The use of polymyxins to treat carbapenem resistant infections in neonates and children.
Thomas R; Velaphi S; Ellis S; Walker AS; Standing JF; Heath P; Sharland M; Dona' D
Expert Opin Pharmacother; 2019 Mar; 20(4):415-422. PubMed ID: 30576264
[TBL] [Abstract][Full Text] [Related]
11. Polymyxin use as a risk factor for colonization or infection with polymyxin-resistant Acinetobacter baumannii after liver transplantation.
Freire MP; Van Der Heijden IM; do Prado GV; Cavalcante LS; Boszczowski I; Bonazzi PR; Rossi F; Guimarães T; D'Albuquerque LA; Costa SF; Abdala E
Transpl Infect Dis; 2014 Jun; 16(3):369-78. PubMed ID: 24725123
[TBL] [Abstract][Full Text] [Related]
12. Rate of polymyxin resistance among Acinetobacter baumannii recovered from hospitalized patients: a systematic review and meta-analysis.
Lima WG; Brito JCM; Cardoso BG; Cardoso VN; de Paiva MC; de Lima ME; Fernandes SOA
Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1427-1438. PubMed ID: 32533271
[TBL] [Abstract][Full Text] [Related]
13.
Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
[TBL] [Abstract][Full Text] [Related]
14. Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.
Tran TB; Cheah SE; Yu HH; Bergen PJ; Nation RL; Creek DJ; Purcell A; Forrest A; Doi Y; Song J; Velkov T; Li J
J Antibiot (Tokyo); 2016 Jun; 69(6):415-21. PubMed ID: 26669752
[TBL] [Abstract][Full Text] [Related]
15. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of resazurin-based rapid test to detect colistin resistance in Acinetobacter baumannii isolates.
Germ J; Poirel L; Kisek TC; Spik VC; Seme K; Premru MM; Zupanc TL; Nordmann P; Pirs M
Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2159-2162. PubMed ID: 31372908
[TBL] [Abstract][Full Text] [Related]
17. Investigation of colistin sensitivity via three different methods in Acinetobacter baumannii isolates with multiple antibiotic resistance.
Sinirtaş M; Akalin H; Gedikoğlu S
Int J Infect Dis; 2009 Sep; 13(5):e217-20. PubMed ID: 19230734
[TBL] [Abstract][Full Text] [Related]
18. Performance of Rapid Polymyxin™ NP and Rapid Polymyxin™ Acinetobacter for the detection of polymyxin resistance in carbapenem-resistant Acinetobacter baumannii and Enterobacterales.
Kon H; Abramov S; Amar Ben Dalak M; Elmaliach N; Schwartz D; Carmeli Y; Lellouche J
J Antimicrob Chemother; 2020 Jun; 75(6):1484-1490. PubMed ID: 32108898
[TBL] [Abstract][Full Text] [Related]
19. Comparative assessment of antimicrobial susceptibility testing for tigecycline and colistin against Acinetobacter baumannii clinical isolates, including multidrug-resistant isolates.
Piewngam P; Kiratisin P
Int J Antimicrob Agents; 2014 Nov; 44(5):396-401. PubMed ID: 25442358
[TBL] [Abstract][Full Text] [Related]
20. Increased antimicrobial susceptibility profiles among polymyxin-resistant Acinetobacter baumannii clinical isolates.
Mendes RE; Fritsche TR; Sader HS; Jones RN
Clin Infect Dis; 2008 Apr; 46(8):1324-6. PubMed ID: 18444879
[No Abstract] [Full Text] [Related]
[Next] [New Search]
